Treatment with dapagliflozin reduced the risk of death or worsening heart failure by 28% compared with standard of care. Dapagliflozin reduced the risk of death or worsening heart failure (HF ...

Please provide your email address to receive an email when new articles are posted on . Dapagliflozin was safe and effective at 1 year among older patients with aortic stenosis and HF who ...

CHICAGO, IL—High-risk older patients with a history of heart failure (HF) who are undergoing transcatheter aortic valve implantation have better outcomes when taking dapagliflozin, results from the ...

Grupi muzikor nga Türkiye ka performuar në edicionin e 14-të të Festivalit Ndërkombëtar të Xhazit “Jazz in Abania", raporton Anadolu. Instituti “Yunus Emre” - Tiranë ka sjellë për ...

CHICAGO — For older patients at high risk for a heart failure event who are scheduled for transcatheter aortic valve implantation (TAVI), dapagliflozin, a sodium glucose cotransporter 2 (SGLT2 ...

We know that the administration of a new diabetes medication, what's called a sodium-glucose cotransporter-2 or SGLT2 inhibitor, dapagliflozin, is beneficial in people that have heart failure.

Në Shqipëri ka filluar edicioni i 14-të i Festivalit Ndërkombëtar të Xhazit “Jazz in Abania", me pjesëmarrjen e grupeve muzikore nga disa vende, raporton Anadolu. Artistët nga Shqipëria ...

Not one but two new studies published today have linked GLP-1 drugs like Ozempic to a decreased risk of developing dementia. There is currently no cure for Alzheimer’s, which affects an ...

AZ sells Forxiga® and is the proprietor of SPC/GB13/021 protecting dapagliflozin, which is based on AZ’s now expired compound patent. This SPC is due to expire in May 2028. AZ also owns an SPC ...

In a reversal of fortune, yesterday (9 April) the UK Court of Appeal awarded AstraZeneca (AZ) an interim injunction keeping Glenmark’s dapagliflozin (dapa) off the UK market until the form of ...

Get Instant Summarized Text (Gist) AI can predict the heart's biological age using 12-lead ECG data, which correlates with mortality and cardiovascular event risks. A biological heart age ...

Studies suggest varying effects based on treatment duration and dosage. For instance, the authors observed dapagliflozin demonstrated a gradual increase in Hct levels over 4 months, while ...